Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2022 | Bidirectional association between systemic lupus erythematosus and macrophage activation syndrome: a nationwide population-based study | Huang, LW; Wei, JC; Chen, DY; Chen, YJ; Tang, KT; Ko, TM ; Chen, HH | Rheumatology (Oxford, England) 61(3), 1123-1132 | | | |
2015 | CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease | Ko, TM ; Kuo, HC; Chang, JS; Chen, SP; Liu, YM; Chen, HW; Tsai, FJ; Lee, YC ; Chen, CH ; Wu, JY ; Chen, YT | Circulation research 116(5), 876-883 | | | |
2019 | Genome-wide transcriptome analysis to further understand neutrophil activation and lncRNA transcript profiles in Kawasaki disease | Ko, Tai-Ming ; Chang, Jeng-Sheng; Chen, Shih-Ping; Liu, Yi-Min; Chang, Chia-Jung; Tsai, Fuu-Jen; Lee, Yi-Ching ; Chen, Chien-Hsiun ; Chen, Yuan-Tsong ; Wu, Jer-Yuarn | SCIENTIFIC REPORTS 9, 328 | | | |
2016 | Identification of PTCSC3 as a novel locus for large-vessel ischemic stroke: A Genome-Wide Association Study | Lee, TH; Ko, TM ; Chen, CH ; Lee, MTM ; Chang, YJ; Chang, CH; Huang, KL; Chang, TY; Lee, JD; Chang, KC; Yang, JT; Wen, MS; Wang, CY; Chen, YT; Hsieh, CS; Chou, SY; Liu, YM; Chen, HW; Liao, HT; Wang, CW; Chen, SP; Lu, LS; Chen, YT ; Wu, JY | Journal of the American Heart Association 5(3), e003003 | | | |
2018 | Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment. | Ko, TM ; Kiyotani, K; Chang, JS; Park, JH; Yew, PY; Chen, YT ; Wu, JY ; Nakamura, Y | Human molecular genetics 27(15), 2671-2677 | | | |
2015 | Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction | Lin, CH; Chen, JK; Ko, TM ; Wei, CY; Wu, JY ; Chung, WH; Chen, SY; Liao, YD ; Hung, SI; Chen, YT | Journal of Allergy and Clinical Immunology 135(4), 1063-1065.e5 | | | |
2021 | Maternal and Perinatal Factors Associated With Kawasaki Disease Among Offspring in Taiwan | Chang, CL; Lin, MC; Lin, CH; Ko, TM | JAMA network open 4(3), e213233 | | | |
2016 | Pharmacogenomics for personalized pain medicine. | Ko, TM ; Wong, CS; Wu, JY ; Chen, YT | Acta Anaesthesiologic Taiwanica 54(1), 24-30 | | | |
2013 | Replication and Meta-Analysis of GWAS Identified Susceptibility Loci in Kawasaki Disease Confirm the Importance of B Lymphoid Tyrosine Kinase (BLK) in Disease Susceptibility | Chia-Jung Chang; Ho-Chang Kuo; Jeng-Sheng Chang; Jong-Keuk Lee; Fuu-Jen Tsai; Chiea Chuen Khor; Li-Ching Chang; Shih-Ping Chen; Tai-Ming Ko ; Yi-Min Liu; Ying-Ju Chen; Young Mi Hong; Gi Young Jang; Martin L. Hibberd; Taco Kuijpers; David Burgner; Michael Levin; Jane C. Burns; Sonia Davila; International Kawasaki Disease Genetics Consortium; Korean Kawasaki Disease Genetics Consortium; Taiwan Kawasaki Disease Genetics Consortium; Yuan-Tsong Chen ; Chien-Hsiun Chen ; Jer-Yuarn Wu ; Yi-Ching Lee | PloS one 8(8), e72037 | | | |
2011 | Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome | Ko, T. M. ; Chung, W. H.; Wei, C. Y.; Shih, H. Y.; Chen, J. K.; Lin, C. H.; Chen, Y. T. ; Hung, S. I. | Journal of Allergy and Clinical Immunology 128(6), 1266-1276.e11 | | | |
2020 | SVAD: A genetic database curates non-ischemic sudden cardiac death-associated variants | Huang, WC; Huang, HT; Chen, PY; Wang, WC; Ko, TM ; Shrestha, S; Yang, CD; Tai, CS; Chiew, MY; Chou, YP; Hu, YF; Huang, HD | PloS one 15(8), e0237731 | | | |
2012 | T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction | Ko, T. M. ; Chen, Y. T. | Expert review of clinical immunology 8(5), 467-77 | | | |
2004 | Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu | Lin, CC; Chou, CW; Shiau, AL; Tu, CF; Ko, TM ; Chen, YL; Yang, BC; Tao, MH; Lai, MD | Molecular therapy: the journal of the American Society of Gene Therapy 10(2), 290-301 | | | |
2015 | Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study | Ko, TM ; Tsai, CY; Chen, SY; Chen, KS; Yu, KH; Chu, CS; Huang, CM; Wang, CR; Weng, CT; Yu, CL; Hsieh, SC; Tsai, JC; Lai, WT; Tsai, WC; Yin, GD; Ou, TT; Cheng, KH; Yen, JH; Liou, TL; Lin, TH; Chen, DY; Hsiao, PJ; Weng, MY; Chen, YM; Chen, CH; Liu, MF; Yen, HW; Lee, JJ; Kuo, MC; Wu, CC; Hung, SY; Luo, SF; Yang, YH; Chuang, HP; Chou, YC; Liao, HT; Wang, CW; Huang, CL; Chang, CS; Lee, MT ; Chen, P; Wong, CS; Chen, CH ; Wu, JY ; Chen, YT ; Shen, CY ; Taiwan Allopurinol-SCAR Consortium | BMJ-British Medical Journal 351, h4848 | | | |